Report Detail
Global (United States, European Union and China) Benztropine Mesylate Market Research Report 2019-2025
- RnM3650153 |
- 06 August, 2019 |
- Global |
- 114 Pages |
- QYResearch |
- Pharma & Healthcare
Benzatropine, also known as benztropine, is an anticholinergic marketed under the trade name Cogentin which is used in the treatment of Parkinson's disease, Parkinsonism, and dystonia.
In 2019, the market size of Benztropine Mesylate is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Benztropine Mesylate.
This report studies the global market size of Benztropine Mesylate, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Benztropine Mesylate sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Akorn
Zydus Pharmaceuticals
ANI Pharmaceuticals
PLIVA
Fresenius Kabi
Hikma Pharmaceuticals
Cipla
Navinta
Aspen Pharmacare
Market Segment by Product Type
Injection
Oral
Market Segment by Application
Parkinsonism
Extrapyramidal symptoms
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Benztropine Mesylate status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Benztropine Mesylate manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Benztropine Mesylate are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Benztropine Mesylate Market Size Growth Rate by Type (2019-2025)
- 1.3.2 Injection
- 1.3.3 Oral
- 1.4 Market Segment by Application
- 1.4.1 Global Benztropine Mesylate Market Share by Application (2019-2025)
- 1.4.2 Parkinsonism
- 1.4.3 Extrapyramidal symptoms
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global Benztropine Mesylate Market Size
- 2.1.1 Global Benztropine Mesylate Revenue 2014-2025
- 2.1.2 Global Benztropine Mesylate Sales 2014-2025
- 2.2 Benztropine Mesylate Growth Rate by Regions
- 2.2.1 Global Benztropine Mesylate Sales by Regions 2014-2019
- 2.2.2 Global Benztropine Mesylate Revenue by Regions 2014-2019
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Benztropine Mesylate Sales by Manufacturers
- 3.1.1 Benztropine Mesylate Sales by Manufacturers 2014-2019
- 3.1.2 Benztropine Mesylate Sales Market Share by Manufacturers 2014-2019
- 3.2 Revenue by Manufacturers
- 3.2.1 Benztropine Mesylate Revenue by Manufacturers (2014-2019)
- 3.2.2 Benztropine Mesylate Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Benztropine Mesylate Market Concentration Ratio (CR5 and HHI)
- 3.3 Benztropine Mesylate Price by Manufacturers
- 3.4 Key Manufacturers Benztropine Mesylate Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Benztropine Mesylate Market
- 3.6 Key Manufacturers Benztropine Mesylate Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Sales and Revenue for Each Type
- 4.1.1 Injection Sales and Revenue (2014-2019)
- 4.1.2 Oral Sales and Revenue (2014-2019)
- 4.2 Global Benztropine Mesylate Sales Market Share by Type
- 4.3 Global Benztropine Mesylate Revenue Market Share by Type
- 4.4 Benztropine Mesylate Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Benztropine Mesylate Sales by Application
6 United States
- 6.1 United States Benztropine Mesylate Breakdown Data by Company
- 6.2 United States Benztropine Mesylate Breakdown Data by Type
- 6.3 United States Benztropine Mesylate Breakdown Data by Application
7 European Union
- 7.1 European Union Benztropine Mesylate Breakdown Data by Company
- 7.2 European Union Benztropine Mesylate Breakdown Data by Type
- 7.3 European Union Benztropine Mesylate Breakdown Data by Application
8 China
- 8.1 China Benztropine Mesylate Breakdown Data by Company
- 8.2 China Benztropine Mesylate Breakdown Data by Type
- 8.3 China Benztropine Mesylate Breakdown Data by Application
9 Rest of World
- 9.1 Rest of World Benztropine Mesylate Breakdown Data by Company
- 9.2 Rest of World Benztropine Mesylate Breakdown Data by Type
- 9.3 Rest of World Benztropine Mesylate Breakdown Data by Application
- 9.4 Rest of World Benztropine Mesylate Breakdown Data by Countries
- 9.4.1 Rest of World Benztropine Mesylate Sales by Countries
- 9.4.2 Rest of World Benztropine Mesylate Revenue by Countries
- 9.4.3 Japan
- 9.4.4 Korea
- 9.4.5 India
- 9.4.6 Southeast Asia
10 Company Profiles
- 10.1 Akorn
- 10.1.1 Akorn Company Details
- 10.1.2 Company Description and Business Overview
- 10.1.3 Sales, Revenue and Market Share of Benztropine Mesylate
- 10.1.4 Benztropine Mesylate Product Introduction
- 10.1.5 Akorn Recent Development
- 10.2 Zydus Pharmaceuticals
- 10.2.1 Zydus Pharmaceuticals Company Details
- 10.2.2 Company Description and Business Overview
- 10.2.3 Sales, Revenue and Market Share of Benztropine Mesylate
- 10.2.4 Benztropine Mesylate Product Introduction
- 10.2.5 Zydus Pharmaceuticals Recent Development
- 10.3 ANI Pharmaceuticals
- 10.3.1 ANI Pharmaceuticals Company Details
- 10.3.2 Company Description and Business Overview
- 10.3.3 Sales, Revenue and Market Share of Benztropine Mesylate
- 10.3.4 Benztropine Mesylate Product Introduction
- 10.3.5 ANI Pharmaceuticals Recent Development
- 10.4 PLIVA
- 10.4.1 PLIVA Company Details
- 10.4.2 Company Description and Business Overview
- 10.4.3 Sales, Revenue and Market Share of Benztropine Mesylate
- 10.4.4 Benztropine Mesylate Product Introduction
- 10.4.5 PLIVA Recent Development
- 10.5 Fresenius Kabi
- 10.5.1 Fresenius Kabi Company Details
- 10.5.2 Company Description and Business Overview
- 10.5.3 Sales, Revenue and Market Share of Benztropine Mesylate
- 10.5.4 Benztropine Mesylate Product Introduction
- 10.5.5 Fresenius Kabi Recent Development
- 10.6 Hikma Pharmaceuticals
- 10.6.1 Hikma Pharmaceuticals Company Details
- 10.6.2 Company Description and Business Overview
- 10.6.3 Sales, Revenue and Market Share of Benztropine Mesylate
- 10.6.4 Benztropine Mesylate Product Introduction
- 10.6.5 Hikma Pharmaceuticals Recent Development
- 10.7 Cipla
- 10.7.1 Cipla Company Details
- 10.7.2 Company Description and Business Overview
- 10.7.3 Sales, Revenue and Market Share of Benztropine Mesylate
- 10.7.4 Benztropine Mesylate Product Introduction
- 10.7.5 Cipla Recent Development
- 10.8 Navinta
- 10.8.1 Navinta Company Details
- 10.8.2 Company Description and Business Overview
- 10.8.3 Sales, Revenue and Market Share of Benztropine Mesylate
- 10.8.4 Benztropine Mesylate Product Introduction
- 10.8.5 Navinta Recent Development
- 10.9 Aspen Pharmacare
- 10.9.1 Aspen Pharmacare Company Details
- 10.9.2 Company Description and Business Overview
- 10.9.3 Sales, Revenue and Market Share of Benztropine Mesylate
- 10.9.4 Benztropine Mesylate Product Introduction
- 10.9.5 Aspen Pharmacare Recent Development
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 Benztropine Mesylate Sales Channels
- 11.2.2 Benztropine Mesylate Distributors
- 11.3 Benztropine Mesylate Customers
12 Market Forecast
- 12.1 Global Benztropine Mesylate Sales and Revenue Forecast 2019-2025
- 12.2 Global Benztropine Mesylate Sales Forecast by Type
- 12.3 Global Benztropine Mesylate Sales Forecast by Application
- 12.4 Benztropine Mesylate Forecast by Regions
- 12.4.1 Global Benztropine Mesylate Sales Forecast by Regions 2019-2025
- 12.4.2 Global Benztropine Mesylate Revenue Forecast by Regions 2019-2025
- 12.5 United States Market Forecast
- 12.6 European Union Market Forecast
- 12.7 China Market Forecast
- 12.8 Rest of World
- 12.8.1 Japan
- 12.8.2 Korea
- 12.8.3 India
13 Research Findings and Conclusion
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.1.1 Research Programs/Design
- 14.1.1.2 Market Size Estimation
- 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
- 14.1.2.1 Secondary Sources
- 14.1.2.2 Primary Sources
- 14.1.1 Methodology/Research Approach
- 14.2 Author Details
Summary:
Get latest Market Research Reports on Benztropine Mesylate. Industry analysis & Market Report on Benztropine Mesylate is a syndicated market report, published as Global (United States, European Union and China) Benztropine Mesylate Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Benztropine Mesylate market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
